Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biotechnologie GmbH, a CDMO for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, have announced a strategic partnership to provide new state-of-the-art fill and finish ...
read more
Wednesday, October 04, 2017
Rentschler Biotechnologie GmbH announced the company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017.
read more
Rentschler Fill Solutions GmbH announced the appointment of Dr. Friedrich Sernetz as Chief Executive Officer.
read more
Monday, November 19, 2018
Rentschler Fill Solutions GmbH has inaugurated its new state-of-the-art facility in Rankweil, Austria.
read more
Rentschler Fill Solutions GmbH, a CMO and expert for aseptic fill and finish services, announced the appointment of Dr. Margit Klotz as General Manager Operations, effective August 1, 2018.
read more
Rentschler Fill Solutions GmbH has received notification from the Austrian Agency for Health and Food Safety that the pharmaceutical manufacturing license for the European market and the certificate for GMP conformity will be extended for an ...
read more
Wednesday, December 07, 2022
Earlier this year, the company kicked off a program with MassBioEd and Worcester Polytechnic Institute (WPI) to train people re-joining the workforce for stable, attractive biotech manufacturing opportunities.
read more
Rentschler obtained the certificate of GMP compliance and the pharmaceutical manufacturing license for the European market from the Austrian Agency for Health and Food Safety.
read more
Rentschler Biopharma and ATUM announced the signing of a full CDMO licensing agreement for the Leap-In Transposase platform.
read more
Rephine announced its merger with Barcelona-based GxP audit organization Forum Auditorias and its technology and manufacturing supply chain compliance consultancy TDV.
read more
Univercells Technologies announced a collaboration with Repligen Corporation to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines.
read more
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set to create new opportunities for biosimilar manufacturers, ...
read more
Wednesday, February 24, 2016
Deceleration of the pharmaceutical patent cliff, combined with expectations of a patent 'slope' for biologics, will support innovative drug manufacturers' U.S. sales, according to the first report in Fitch Ratings' 'Navigating the Pharmaceutical ...
read more
Wednesday, December 05, 2018
The global biopharmaceuticals contract manufacturing market size is expected to reach USD 21.7 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 7.5% during the forecast period.
read more
Thursday, December 22, 2016
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a new report by Grand View Research, Inc. The Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical ...
read more